15.49
+0.56(+3.75%)
Currency In USD
| Previous Close | 14.93 |
| Open | 14.96 |
| Day High | 15.54 |
| Day Low | 14.83 |
| 52-Week High | 21 |
| 52-Week Low | 9.22 |
| Volume | 604,262 |
| Average Volume | 1.13M |
| Market Cap | 712.74M |
| PE | -154.9 |
| EPS | -0.1 |
| Moving Average 50 Days | 11.87 |
| Moving Average 200 Days | 14.8 |
| Change | 0.56 |
If you invested $1000 in AxoGen, Inc. (AXGN) 10 years ago, it would be worth $3,961.64 as of August 18, 2025 at a share price of $15.49. Whereas If you bought $1000 worth of AxoGen, Inc. (AXGN) shares 5 years ago, it would be worth $1,373.23 as of August 18, 2025 at a share price of $15.49.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Axogen, Inc. to participate at the Canaccord Genuity 45th Annual Growth Conference
GlobeNewswire Inc.
Jul 29, 2025 8:10 PM GMT
ALACHUA, Fla. and TAMPA, Fla., July 29, 2025 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for the restoration of peripheral nerve function, today announced that managemen
Axogen, Inc. to report 2025 second quarter financial results on August 5, 2025
GlobeNewswire Inc.
Jul 22, 2025 8:05 PM GMT
ALACHUA, Fla. and TAMPA, Fla., July 22, 2025 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for the restoration of peripheral nerve function, today announced that it will r
Axogen, Inc to Participate at Goldman Sachs Global Healthcare Conference
GlobeNewswire Inc.
May 28, 2025 12:00 PM GMT
ALACHUA, Fla. and TAMPA, Fla., May 28, 2025 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today announced that Michael Dale, board director,